CGM
HZNP
Capital Growth Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-250,000
| Closed | -$19.4M | – | 77 |
|
|
2020
Q3 | $19.4M | Sell |
250,000
-290,000
| -54% | -$22.5M | 2.03% | 22 |
|
|
2020
Q2 | $30M | Sell |
540,000
-340,000
| -39% | -$18.9M | 3.49% | 7 |
|
|
2020
Q1 | $26.1M | Buy |
880,000
+35,000
| +4% | +$1.04M | 3.66% | 8 |
|
|
2019
Q4 | $30.6M | Buy |
+845,000
| New | +$30.6M | 2.47% | 18 |
|
|
2019
Q2 | – | Sell |
-205,000
| Closed | -$5.42M | – | 69 |
|
|
2019
Q1 | $5.42M | Buy |
205,000
+30,000
| +17% | +$793K | 0.33% | 42 |
|
|
2018
Q4 | $3.42M | Buy |
175,000
+25,000
| +17% | +$489K | 0.21% | 43 |
|
|
2018
Q3 | $2.94M | Buy |
+150,000
| New | +$2.94M | 0.15% | 44 |
|
|
2017
Q1 | – | Sell |
-1,530,000
| Closed | -$24.8M | – | 76 |
|
|
2016
Q4 | $24.8M | Buy |
1,530,000
+530,000
| +53% | +$8.58M | 1.1% | 33 |
|
|
2016
Q3 | $18.1M | Buy |
+1,000,000
| New | +$18.1M | 0.86% | 35 |
|
|
2016
Q2 | – | Sell |
-330,000
| Closed | -$5.47M | – | 71 |
|
|
2016
Q1 | $5.47M | Buy |
330,000
+125,000
| +61% | +$2.07M | 0.23% | 43 |
|
|
2015
Q4 | $4.44M | Buy |
+205,000
| New | +$4.44M | 0.15% | 48 |
|